Wang, X., Bera, K., Barrera, C., Zhou, Y., Lu, C., Vaidya, P., Yang, M., Schmid, R., Berezowska, S., Choi, H., Velcheti, V., & Madabhushi, A.(2021).A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.EBioMedicine.
WAng, X., Bera, K., Barrera, C., Zhou, Y., Lu, C., Vaidya, P., Fu, P., Yang, M., Schmid, R., Berezowska, S., Choi, H., Velcheti, V., & Madabhushi, A.(2021).A prognostic and predictive computational pathology image signature for added benefit of adjuvant chemotherapy in early stage non-small-cell lung cancer.EBIOMEDICINE,69
Lu, C., Bera, K., WAng, X., Prasanna, P., Xue, Z., Janowczyk, A., Beig, N., Yang, M., Fu, P., Lewis, J., Choi, H., Schmid, R., Berezowska, S., Schalper, K., Rimm, D., Velcheti, V., & Madabhushi, A.(2020).A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.The Lancet Digital Health,2(11),e594-e606.
Lu, C., Bera, K., WAng, X., Prasanna, P., Xue, Z., Janowczyk, A., Beig, N., Yang, M., Fu, P., Lewis, J., Choi, H., Schmid, R., Berezowska, S., Schalper, K., Rimm, D., Velcheti, V., & Madabhushi, A.(2020).A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study.The Lancet Digital Health,2(11),e594-e606.
